Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...

A daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company ...

Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...

Unfortunately, doctors had no say in which medicines were selected. And they’ll have almost no input into the negotiation process unless changes are made to policies in force at the Centers for ...

An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...

A daily pill developed by Eli Lilly significantly lowered blood sugar levels and led to weight loss in people with Type 2 ...

Eli Lilly’s recent announcement of the success of its daily obesity pill, orforglipron, in the first late-stage trial has generated significant buzz in the pharmaceutical industry. The trial, which ...

Ashland, Ky.-based physician Matthew Lewis, MD, owner of Lewis Family Care, pleaded guilty to receiving and selling misbranded drugs with intent to defraud or mislead, according to an April 14 news ...